Peter N Fiorica

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Dna Methylation

Cardiovascular Risk Factors

Top Venues

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Peter N Fiorica, Haiyang Sheng, Qianqian Zhu, Janise M Roh, Cecile A Laurent, Isaac J Ergas, Jennifer Delmerico, Marilyn L Kwan, Lawrence H Kushi, Christine B Ambrosone, Song Yao
A Mendelian Randomization Analysis of 55 Genetically Predicted Metabolic Traits with Breast Cancer Survival Outcomes in the Pathways Study. Cancer research communications 3 (6) (2023)
Peter N Fiorica, Haiyang Sheng, Qianqian Zhu, Janise M Roh, Cecile A Laurent, Isaac J Ergas, Jennifer Delmerico, Marilyn L Kwan, Lawrence H Kushi, Christine B Ambrosone, Song Yao
A Mendelian Randomization Analysis of 55 Genetically Predicted Metabolic Traits with Breast Cancer Survival Outcomes in the Pathways Study. Cancer research communications 3 (6) (2023)
Peter N Fiorica, Haiyang Sheng, Qianqian Zhu, Janise M Roh, Cecile A Laurent, Isaac J Ergas, Jennifer Delmerico, Marilyn L Kwan, Lawrence H Kushi, Christine B Ambrosone, Song Yao
A Mendelian Randomization Analysis of 55 Genetically Predicted Metabolic Traits with Breast Cancer Survival Outcomes in the Pathways Study. Cancer research communications 3 (6) (2023)
Peter N Fiorica, Haiyang Sheng, Qianqian Zhu, Janise M Roh, Cecile A Laurent, Isaac J Ergas, Jennifer Delmerico, Marilyn L Kwan, Lawrence H Kushi, Christine B Ambrosone, Song Yao
A Mendelian Randomization Analysis of 55 Genetically Predicted Metabolic Traits with Breast Cancer Survival Outcomes in the Pathways Study. Cancer research communications 3 (6) (2023)
Peter N Fiorica, Haiyang Sheng, Qianqian Zhu, Janise M Roh, Cecile A Laurent, Isaac J Ergas, Jennifer Delmerico, Marilyn L Kwan, Lawrence H Kushi, Christine B Ambrosone, Song Yao
A Mendelian Randomization Analysis of 55 Genetically Predicted Metabolic Traits with Breast Cancer Survival Outcomes in the Pathways Study. Cancer research communications 3 (6) (2023)